EUVIMEDEUVIMED entdecken
Open Access

Differential Effects of Cardiometabolic Risk Factors on All-Cause Mortality in United States Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Matthew Dukewich, Jennifer L Dodge, Liyun Yuan, Norah A Terrault

Clinical Gastroenterology and Hepatology · 2026-05 · 24 (5) · 1344-1353

DOI: 10.1016/j.cgh.2025.09.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-05. Verfasst von Matthew Dukewich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastrointestinal and Liver Diseases, University of Southern California Keck School of Medicine, Los Angeles, California. Hauptthemen laut MEDLINE: Cardiometabolic Risk Factors, Fatty Liver. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, University of Southern California, NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is defined by abnormalities in cardiometabolic risk factors (CMRFs). Characterizing the contribution of individual CMRFs to clinical outcomes may guide prioritization of interventions. We evaluated the association of individual CMRFs with all-cause mortality in United States adults with MASLD. METHODS: Participants in the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) and continuous NHANES (1999-2018) were linked to mortality data through 2019. Adults >20 years of age were included if their Fatty Liver Index (FLI) was >60 and they had at least one CMRF (overweight/obesity, glucose intolerance, high blood pressure, triglycerides, or low high-density lipoprotein [HDL]). Cox regression analyzed risk of all-cause mortality adjusted for age, sex, and Fibrosis-4 (FIB-4). RESULTS: Among 21,872 participants included (mean age, 50 years; 53% male), the mean body mass index (BMI) was 33.6 kg/m2 with a median of 3 CMRF (99.5% overweight/obese, 55% glucose intolerance, 58% high blood pressure, 67% high triglycerides, 40% low HDL). In adjusted analysis of individual CMRF, high blood pressure (adjusted hazard ratio [aHR], 1.39; 95% confidence interval [CI], 1.24-1.55; P 45 kg/m2 (aHR, 1.64; 95% CI, 1.27-2.14; P < .001) compared with those with a BMI 25 to 30 kg/m2. In age-adjusted analysis, the number of CMRFs was associated with greater risk for mortality (aHR, 1.15 per additional CMRF; 95% CI, 1.10-1.20; P < .001) CONCLUSIONS: The differential risk for mortality between individual CMRFs supports distinct clinical profiles in MASLD. This study found that high blood pressure and glucose intolerance exerted the greatest risk for all-cause mortality in those with MASLD, suggesting a role for prioritization of CMRF optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiometabolic Risk FactorsFatty LiverHumansMaleFemaleMiddle AgedUnited StatesNutrition SurveysAdultAgedBody Mass IndexRisk Factors

Stichwörter der Autor:innen

CirrhosisFatty LiverMetabolic SyndromeNonalcoholic Fatty Liver DiseaseNutrition Surveys

Autor:innen und Institutionen

  • Division of Gastrointestinal and Liver Diseases, University of Southern California Keck School of Medicine, Los Angeles, California.
  • Division of Gastrointestinal and Liver Diseases, University of Southern California Keck School of Medicine, Los Angeles, California; Department of Population and Public Health Sciences, University of Southern California…
  • Division of Gastrointestinal and Liver Diseases, University of Southern California Keck School of Medicine, Los Angeles, California. Electronic address: Norah.Terrault@med.usc.edu.

Förderung

  • NIDDK NIH HHS
  • University of Southern California
  • NIDDK

Zitieren

APA

Dukewich, M., Dodge, J. L., Yuan, L., & Terrault, N. A. (2026). Differential Effects of Cardiometabolic Risk Factors on All-Cause Mortality in United States Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Clinical Gastroenterology and Hepatology, 24(5), 1344-1353. https://doi.org/10.1016/j.cgh.2025.09.003

Vancouver

Dukewich M, Dodge JL, Yuan L, Terrault NA. Differential Effects of Cardiometabolic Risk Factors on All-Cause Mortality in United States Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Clinical Gastroenterology and Hepatology. 2026;24(5):1344-1353. doi:10.1016/j.cgh.2025.09.003

BibTeX
@article{Dukewich2026,
  author = {Dukewich, Matthew and Dodge, Jennifer L and Yuan, Liyun and Terrault, Norah A},
  title = {Differential Effects of Cardiometabolic Risk Factors on All-Cause Mortality in United States Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {5},
  pages = {1344--1353},
  doi = {10.1016/j.cgh.2025.09.003}
}
Kostenlos starten →